Europe IV Dressing Market Size, Share & Trends Analysis Report By Type (Transparent, and Translucent), By End-use (Hospitals, Clinics, and Others), By Country and Growth Forecast, 2024 - 2031

Europe IV Dressing Market Size, Share & Trends Analysis Report By Type (Transparent, and Translucent), By End-use (Hospitals, Clinics, and Others), By Country and Growth Forecast, 2024 - 2031


The Europe IV Dressing Market would witness market growth of 5.5% CAGR during the forecast period (2024-2031). In the year 2021, the Europe market's volume surged to 10,972.4 thousand units, showcasing a growth of 17.1% (2020-2023).

In clinics, IV dressings are integral components of the market, serving essential functions in patient care. These dressings provide a protective barrier over intravenous access points, safeguarding against infection and minimizing the risk of contamination. They ensure the secure attachment of IV catheters, preventing accidental dislodgement and maintaining the continuity of treatment delivery. Therefore, the Clinics in Germany consumed 847.8 thousand units in 2023.

The Germany market dominated the Europe IV Dressing Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $77.4 Million by 2031. The UK market is exhibiting a CAGR of 4.5% during (2024 - 2031). Additionally, The France market would experience a CAGR of 6.3% during (2024 - 2031).

These dressings are crucial in securing IV catheters and preventing accidental dislodgment or movement that can lead to complications or treatment interruption. They provide stability and support to the catheter, ensuring uninterrupted delivery of medications and fluids. High-quality dressings are designed to be comfort table for patients, minimizing discomfort and irritation at the insertion site. They are typically breathable and flexible, providing ease of movement and reducing the risk of skin irritation or allergic reactions.

Furthermore, some dressings incorporate advanced moisture management technology to absorb excess exudate from the wound site while maintaining an optimal moisture level for healing. This helps to prevent maceration of the surrounding skin and promotes a healthy healing environment. Transparent allow healthcare providers to monitor the insertion site without needing frequent dressing changes. This visibility enables early detection of complications such as infiltration, phlebitis, or signs of infection.

Senior citizens in the UK are more prone to health issues that may necessitate hospitalization, such as cardiovascular diseases, respiratory conditions, and infections. As per the UK government’s report named “Future of an aging population,” by 2040, nearly one in seven people is projected to be over 75. By 2037, there are projected to be 1.42 million more households headed by someone aged 85 or over, an increase of 161% over 25 years. The proportion of the working-age population aged between 50 and the state pension age (SPA) will increase from 26% in 2012 to 34% in 2050, an increase of over 5.5 million people. Thus, all these factors will uplift the regional market’s expansion in the coming years.

Based on Type, the market is segmented into Transparent, and Translucent. Based on End-use, the market is segmented into Hospitals, Clinics, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled
  • 3M Company
  • Cardinal Health, Inc.
  • Smith & Nephew PLC
  • McKesson Corporation
  • Covalon Technologies Ltd.
  • Becton, Dickinson, and Company
  • Molnlycke Health Care AB
  • DermaRite Industries, LLC
  • Dynarex Corporation
  • Essity AB (BSN medical)
Europe IV Dressing Market Report Segmentation

By Type (Volume, Thousand Units, USD Billion, 2020-2031)
  • Transparent
  • Translucent
By End-use (Volume, Thousand Units, USD Billion, 2020-2031)
  • Hospitals
  • Clinics
  • Others
By Country (Volume, Thousand Units, USD Billion, 2020-2031)
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe IV Dressing Market, by Type
1.4.2 Europe IV Dressing Market, by End-use
1.4.3 Europe IV Dressing Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Europe IV Dressing Market by Type
4.1 Europe Transparent Market by Country
4.2 Europe Translucent Market by Country
Chapter 5. Europe IV Dressing Market by End-use
5.1 Europe Hospitals Market by Country
5.2 Europe Clinics Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe IV Dressing Market by Country
6.1 Germany IV Dressing Market
6.1.1 Germany IV Dressing Market by Type
6.1.2 Germany IV Dressing Market by End-use
6.2 UK IV Dressing Market
6.2.1 UK IV Dressing Market by Type
6.2.2 UK IV Dressing Market by End-use
6.3 France IV Dressing Market
6.3.1 France IV Dressing Market by Type
6.3.2 France IV Dressing Market by End-use
6.4 Russia IV Dressing Market
6.4.1 Russia IV Dressing Market by Type
6.4.2 Russia IV Dressing Market by End-use
6.5 Spain IV Dressing Market
6.5.1 Spain IV Dressing Market by Type
6.5.2 Spain IV Dressing Market by End-use
6.6 Italy IV Dressing Market
6.6.1 Italy IV Dressing Market by Type
6.6.2 Italy IV Dressing Market by End-use
6.7 Rest of Europe IV Dressing Market
6.7.1 Rest of Europe IV Dressing Market by Type
6.7.2 Rest of Europe IV Dressing Market by End-use
Chapter 7. Company Profiles
7.1 3M Company
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Trials and Approvals:
7.1.6 SWOT Analysis
7.2 Cardinal Health, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 SWOT Analysis
7.3 Smith & Nephew PLC
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional and Segmental Analysis
7.3.4 Research & Development Expense
7.3.5 SWOT Analysis
7.4 McKesson Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental Analysis
7.4.4 Research & Development Expense
7.4.5 SWOT Analysis
7.5 Covalon Technologies Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Research & Development Expenses
7.6 Becton, Dickinson, and Company
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 SWOT Analysis
7.7 Molnlycke Health Care AB
7.7.1 Company Overview
7.7.2 SWOT Analysis
7.8 DermaRite Industries, LLC
7.8.1 Company Overview
7.8.2 SWOT Analysis
7.9 Dynarex Corporation
7.9.1 Company Overview
7.9.2 SWOT Analysis
7.10. Essity AB (BSN medical)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses
7.10.5 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings